Increased incidence of thyrotoxicosis after iodine supplementation in an iodine sufficient area.
The aim of this study was to determine the incidence rate of thyrotoxicosis (TT) before and during dietary-iodine supplementation in an iodine-sufficient area.


METHODS
the study was carried out in Vigo, South Galicia (northwest of Spain), from January 1977 to December 1989. The mean population throughout the study period was 267,330 inhabitants (47% males and 53% females). From January 1985, a mandatory consumption of iodinized salt on the whole population started in Galicia. This region was considered as an iodine-deficient area but Vigo is an iodine-sufficient area.


METHODS
all newly diagnosed TT cases in Vigo city within the study period were included in this study. Diagnosis of TT was based on the clinical manifestations, an elevated level of T4 and suppressed TSH values. The difference between diffuse and nodular forms of goiter was assessed by scintigraphy. The average incidence rate (AIR) was determined in two periods, before (period A, 1977-1984) and during (period B, 1985-1989) iodine supplementation.


RESULTS
the AIR throughout the whole study period was 4.89 new cases per 100,000 population, 95% confidence limits 4.16 to 5.63; AIR was 1.34 for males and 8.03 for females. AIR in period B was significantly higher with respect to period A, 7.68 and 3.10 per 100,000 respectively. The confidence interval for the difference was from -20.4 to 30.1, p < 0.05. The increase of the incidence of TT was comprised of both nodular and diffuse goiters.


CONCLUSIONS
dietary iodinesupplementation in iodine-sufficient areas may induce an increase of the incidence of TT.(ABSTRACT TRUNCATED AT 250 WORDS)
Galofré
J C
JC
Endocrine Service, General Hospital of Vigo, Spain.
Fernández-Calvet
L
L
Ríos
M
M
García-Mayor
R V
RV
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D005260:Female; D005527:Food, Fortified; D006042:Goiter / Q000517:prevention & control; D006801:Humans; D015994:Incidence; D007455:Iodine / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D013030:Spain / Q000453:epidemiology; D013971:Thyrotoxicosis / Q000175:diagnosis / Q000453:epidemiology*
D007455:Iodine